Search clinical trials for: Treated by bispecific antibodies, teclistamab or elranatamab in usual care

Total 6 results

Assistance Publique - Hôpitaux de Paris

Completed

A Real-World Study of Bispecific Antibodies in Multiple Myeloma (BISPEMM)

Multiple Myeloma

France
Vrije Universiteit Brussel

Completed

Prognostic Factor Research of Sensory Profiles in Development of Central Sensitization

Low Back Pain | Central Sensitisation | Sensory Profiles | Nociplastic Pain

Belgium
Medco Health Solutions, Inc.
Coventry Health Care, Inc.

Terminated

Coventry Outcomes Study of Seniors (COSS): A Comparative Effectiveness Study to Evaluate the Effect of a Multidisciplinary Team's Intervention on the Incidence of Nonelective Hospitalizations in a Medicare Population (COSS)

Heart Failure | Cardiovascular Disease | Diabetes | Chronic Obstructive Pulmonary Disease | Osteoporosis

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

Neuroblastoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others

Thyroid Cancer | Papillary Microcarcinoma

United States
Memorial Sloan Kettering Cancer Center
Pfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of Virginia

Completed

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Neurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial Hemangiopericytoma

United States

Search clinical trials for: Treated by bispecific antibodies, teclistamab or elranatamab in usual care

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations